{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:30:37Z","timestamp":1786984237285,"version":"build-2736575974"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"33","license":[{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,8,14]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Acute non-high-risk pulmonary thromboembolism (PTE) is generally relieved within months of anticoagulation treatment initiation. However, some patients experience complications. This study aimed to assess the efficacy of urokinase thrombolysis in intermediate-risk PTE using a modified pulmonary artery obstruction index (PAOI). We retrospectively assessed the data of 85 patients with acute PTE and venous thromboembolism of the lower extremities treated between January 2018 and January 2023. All patients underwent inferior vena cava filter implantation and thrombolysis via the dorsal foot vein. We evaluated thrombolysis efficacy using computed tomography pulmonary angiography, Doppler echocardiography, D-dimer (D-D) levels, and PAOI. The effects of age, preoperative D-D level, urokinase dosage, and thrombolysis time on efficacy and safety were analyzed. Complete thrombus dissolution in pulmonary arteries occurred in 67.1% of patients (thrombolysis efficacy, 100%). The modified PAOI\/40, artery diameter, and artery-to-aorta diameter ratio showed significant improvements post-thrombolysis. The average daily usage of urokinase ranged from 36.36\u2005\u00d7\u200510\n                      <jats:sup>4<\/jats:sup>\n                      to 100\u2005\u00d7\u200510\n                      <jats:sup>4<\/jats:sup>\n                      units. Spearman rank correlation test revealed a relationship between PAOI change rate and pre-intervention D-D level (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      \u2005=\u20050.291;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.007) and average daily urokinase dosage (\n                      <jats:italic toggle=\"yes\">r<\/jats:italic>\n                      = \u20130.341;\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.001). In multinomial logistic regression, total urokinase dosage (odds ratio\u2005=\u20051.052,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.032) and thrombolysis time (odds ratio\u2005=\u20050.012,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.032) were identified as significant factors. During follow-up, thromboembolism recurred in 2 cases; clinical manifestations of right heart insufficiency were not observed in other patients. Higher preoperative D-D levels may suggest a better thrombolytic effect in intermediate-risk acute PTE. An appropriate daily dosage of urokinase may yield good therapeutic effects. Managing urokinase dosage and duration helps prevent serious bleeding complications.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000050141","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T18:01:17Z","timestamp":1786730477000},"page":"e50141","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Modified pulmonary artery obstruction index for thrombolysis assessment in intermediate-risk pulmonary thromboembolism"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3380-8922","authenticated-orcid":false,"given":"Weida","family":"Wu","sequence":"first","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianyang","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guohui","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanzhen","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjia","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Interventional and Vascular Surgery, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunying","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Putian University, Putian, Fujian, People\u2019s Republic of China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260817","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1513\/pats.200605-112LR","article-title":"Incidence and prevalence of chronic thromboembolic pulmonary hypertension: from acute to chronic pulmonary embolism.","volume":"3","author":"Tapson","year":"2006","journal-title":"Proc Am Thorac Soc"},{"key":"R2-20260817","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/j.hlc.2016.11.016","article-title":"Long-term antiarrhythmic effects of thrombolytic therapy in pulmonary embolism.","volume":"26","author":"Hayiro\u011flu","year":"2017","journal-title":"Heart Lung Circ"},{"key":"R3-20260817","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1183\/09031936.00049312","article-title":"Risk factors and basic mechanisms of chronic thromboembolic pulmonary hypertension: a current understanding.","volume":"41","author":"Lang","year":"2013","journal-title":"Eur Respir J"},{"key":"R4-20260817","doi-asserted-by":"crossref","first-page":"2551","DOI":"10.1111\/crj.12955","article-title":"Incidence and risk factors of chronic thromboembolic pulmonary hypertension in patients with diagnosis of pulmonary embolism for the first time in real world.","volume":"12","author":"Yu","year":"2018","journal-title":"Clin Respir J"},{"key":"R5-20260817","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa1302097","article-title":"Fibrinolysis for patients with intermediate-risk pulmonary embolism.","volume":"370","author":"Meyer","year":"2014","journal-title":"N Engl J Med"},{"key":"R6-20260817","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1378\/chest.09-0765","article-title":"Efficacy and safety of low dose recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial.","volume":"137","author":"Wang","year":"2010","journal-title":"Chest"},{"key":"R7-20260817","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1136\/jim-2021-001816","article-title":"Low-dose thrombolysis for submassive pulmonary embolism.","volume":"69","author":"Yilmaz","year":"2021","journal-title":"J Investig Med"},{"key":"R8-20260817","first-page":"125","article-title":"Consensus among Chinese experts on standard interventional therapy for deep venous thrombosis of lower extremity.","volume":"1","author":"Gu","year":"2018","journal-title":"J Interv Med"},{"key":"R9-20260817","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/eurheartj\/ehz405","article-title":"2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism developed in collaboration with the European Respiratory Society (ERS).","volume":"41","author":"Konstantinides","year":"2020","journal-title":"Eur Heart J"},{"issue":"2 Suppl","key":"R10-20260817","doi-asserted-by":"crossref","first-page":"e351S","DOI":"10.1378\/chest.11-2299","article-title":"Diagnosis of DVT: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines.","volume":"141","author":"Bates","year":"2012","journal-title":"Chest"},{"key":"R11-20260817","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1111\/jth.15866","article-title":"Frequency and predictors for chronic thromboembolic pulmonary hypertension after a first unprovoked pulmonary embolism: results from PADIS studies.","volume":"20","author":"Fauch\u00e9","year":"2022","journal-title":"J Thromb Haemost"},{"key":"R12-20260817","doi-asserted-by":"crossref","first-page":"2200879","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension.","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"R13-20260817","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/j.ihj.2021.10.003","article-title":"Incidence and predictors of chronic thromboembolic pulmonary hypertension following acute pulmonary embolism: an echocardiography guided approach.","volume":"73","author":"Agarwal","year":"2021","journal-title":"Indian Heart J"},{"key":"R14-20260817","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.hrtlng.2022.06.025","article-title":"Investigation of the need for computed tomography pulmonary angiography in the decision to discontinue treatment for pulmonary thromboembolism.","volume":"56","author":"\u00c7elik","year":"2022","journal-title":"Heart Lung"},{"key":"R15-20260817","doi-asserted-by":"crossref","first-page":"800","DOI":"10.2214\/AJR.19.22541","article-title":"CT-Based biomarkers for prediction of chronic thromboembolic pulmonary hypertension after an acute pulmonary embolic event.","volume":"215","author":"Lorenz","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"R16-20260817","doi-asserted-by":"crossref","first-page":"970","DOI":"10.3324\/haematol.2009.018960","article-title":"Prospective cardiopulmonary screening program to detect chronic thromboembolic pulmonary hypertension in patients after acute pulmonary embolism.","volume":"95","author":"Klok","year":"2010","journal-title":"Haematologica"},{"key":"R17-20260817","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report.","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"R18-20260817","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.12998\/wjcc.v11.i8.1702","article-title":"Evolving paradigm of thrombolysis in pulmonary embolism: comprehensive review of clinical manifestations, indications, recent advances and guideline.","volume":"11","author":"Ochani","year":"2023","journal-title":"World J Clin Cases"},{"key":"R19-20260817","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jvs.2007.05.026","article-title":"Uses of different D-dimer levels can reduce the need for venous duplex scanning to rule out deep vein thrombosis in patients with symptomatic pulmonary embolism.","volume":"46","author":"Yamaki","year":"2007","journal-title":"J Vasc Surg"},{"key":"R20-20260817","doi-asserted-by":"crossref","first-page":"791","DOI":"10.2214\/AJR.12.8624","article-title":"The rate of resolution of clot burden measured by pulmonary CT angiography in patients with acute pulmonary embolism.","volume":"200","author":"Aghayev","year":"2013","journal-title":"AJR Am J Roentgenol"},{"key":"R21-20260817","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/crj.13001","article-title":"The predictive value of plasma osmolality for in-hospital mortality in patients with acute pulmonary embolism.","volume":"13","author":"\u00d6z","year":"2019","journal-title":"Clin Respir J"},{"key":"R22-20260817","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1253\/circj.CJ-24-0630","article-title":"Predicting short-term mortality in patients with acute pulmonary embolism with deep learning.","volume":"89","author":"Cicek","year":"2025","journal-title":"Circ J"},{"key":"R23-20260817","doi-asserted-by":"crossref","first-page":"106293","DOI":"10.1016\/j.rmed.2020.106293","article-title":"Interventional and pharmacological management of chronic thromboembolic pulmonary hypertension.","volume":"177","author":"Ghofrani","year":"2021","journal-title":"Respir Med"},{"key":"R24-20260817","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1016\/j.chest.2021.05.052","article-title":"Results from the United States chronic thromboembolic pulmonary hypertension registry: enrollment characteristics and 1-year follow-up.","volume":"160","author":"Kerr","year":"2021","journal-title":"Chest"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:00:32Z","timestamp":1786982432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000050141"}},"subtitle":["A retrospective cohort study"],"short-title":[],"issued":{"date-parts":[[2026,8,14]]},"references-count":24,"journal-issue":{"issue":"33","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000050141","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,14]]},"assertion":[{"value":"2025-11-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-26","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}